Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy

Hsueh Liang Chu, Hung Wei Chen, Shin Hua Tseng, Ming Hua Hsu, Li Ping Ho, Fu Hsuan Chou, Md Phd Hsing Yuan Li, Yu Chuan Chang, Pei Hsin Chen, Li Yun Tsai, Ching Chung Chou, Jyh Shin Chen, Tsai Mu Cheng, Chia Ching Chang

研究成果: 雜誌貢獻文章同行評審

16 引文 斯高帕斯(Scopus)


It is highly desirable to develop a therapeutic, observable nanoparticle complex for specific targeting in cancer therapy. Growth hormone (GH) and its antagonists have been explored as cancer cell-targeting molecules for both imaging and therapeutic applications. In this study, a low toxicity, biocompatible, therapeutic, and observable GH-nanoparticle complex for specifically targeting growth hormone receptor (GHR) in cancer cells was synthesized by conjugating GH with green fluorescence protein and carboxylated nanodiamond. Moreover, we have shown that this complex can be triggered by laser irradiation to create a "nanoblast" and induce cell death in the A549 non-small-cell lung cancer cell line via the apoptotic pathway. This laser-mediated, cancer-targeting platform can be widely used in cancer therapy. Small but significant: A new nanosurgery platform was formed using a laser-mediated, cancer-targeting nanodiamond (ND) complex. Laser irradiation at 532 nm created a nanoblast of the ND complex and induced cell death within a growth-hormone-receptor-containing lung cancer cell line.
頁(從 - 到)1023-1029
出版狀態已發佈 - 5月 2014

ASJC Scopus subject areas

  • 生物化學
  • 分子醫學
  • 藥理
  • 藥物發現
  • 藥理學、毒理學和藥劑學 (全部)
  • 有機化學


深入研究「Development of a growth-hormone-conjugated nanodiamond complex for cancer therapy」主題。共同形成了獨特的指紋。